Novelix Pharmaceuticals Limited (BOM:536565)
India
· Delayed Price · Currency is INR 53.90
+0.80 (1.51%)
At close: Mar 10, 2026
Novelix Pharmaceuticals Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 0.85 | 0.1 | -0.6 | -20.27 | -37.64 | Upgrade
|
| Depreciation & Amortization | - | 0.38 | 0.38 | 0.56 | 0.8 | 2.09 | Upgrade
|
| Other Amortization | - | - | - | - | 0.22 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 4.57 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | 15 | -0.1 | Upgrade
|
| Other Operating Activities | - | 0.23 | -2.97 | -5.14 | 4.6 | -2.62 | Upgrade
|
| Change in Accounts Receivable | - | -225.94 | 3.3 | -16.52 | 22.79 | 50.43 | Upgrade
|
| Change in Inventory | - | 3.51 | -3.74 | -2.89 | -0.7 | -0.2 | Upgrade
|
| Change in Accounts Payable | - | 84.12 | -0.52 | 0.53 | -11.15 | 3.94 | Upgrade
|
| Operating Cash Flow | - | -136.85 | -3.43 | -24.05 | 15.86 | 15.93 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -0.42% | 153.83% | Upgrade
|
| Capital Expenditures | - | -1.06 | - | -0.04 | -17.98 | -0.3 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.18 | - | - | - | Upgrade
|
| Investment in Securities | - | 30.21 | -1.39 | 22.84 | 15.08 | -1.06 | Upgrade
|
| Other Investing Activities | - | 0.16 | 3.07 | -22.04 | -4.69 | 2.71 | Upgrade
|
| Investing Cash Flow | - | 29.3 | 1.86 | 0.75 | -7.6 | 1.36 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -7.67 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | - | -7.67 | Upgrade
|
| Issuance of Common Stock | - | 30.65 | - | - | - | - | Upgrade
|
| Other Financing Activities | - | 82.5 | - | - | - | - | Upgrade
|
| Financing Cash Flow | - | 113.15 | - | - | - | -7.67 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | 0 | - | -0 | 0 | Upgrade
|
| Net Cash Flow | - | 5.61 | -1.57 | -23.3 | 8.26 | 9.62 | Upgrade
|
| Free Cash Flow | - | -137.91 | -3.43 | -24.1 | -2.12 | 15.63 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 199.65% | Upgrade
|
| Free Cash Flow Margin | - | -44.87% | -7.58% | -125.49% | -2.38% | 16.31% | Upgrade
|
| Free Cash Flow Per Share | - | -14.69 | -0.33 | -2.98 | -0.26 | 1.93 | Upgrade
|
| Levered Free Cash Flow | - | -159.47 | 4.48 | 10.27 | -12.33 | 34.19 | Upgrade
|
| Unlevered Free Cash Flow | - | -159.47 | 4.48 | 10.27 | -11.97 | 34.53 | Upgrade
|
| Change in Working Capital | - | -138.3 | -0.96 | -18.87 | 10.94 | 54.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.